[1] Isabelle A, Nicolas V, CécileML, et al. Dose monitoring bispectral index or spectral entropy reduce sevoflurane use [J] ? Anesth Analg, 2006, 103(6): 1469-1477. [2] Picard P, Bazin JE, Conio N, et al. Ketorolac potentiates morphine in postoperative patient-controlled analgesia[J]. Pain, 1997, 73(3): 401-406. [3] Dowd NP, Cheng DC, Karski JM, et al. Intraoperative awareness in fast-track cardiac anesthesia[J]. Anesthesiology, 1998, 89(5): 1068-1073. [4] Hentgen E, Houfani M, Billard V, et al. Propofol-sufentanil anesthesia for thyroid surgery: optimal concentrations for hemodynamic and electroencephalogram stability, and recovery features[J]. Anesth Analg, 2002, 95(3): 597-605. [5] Patel SS, Goa KL. Sevoflurane: a review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia[J]. Drugs, 1996, 51(4): 658-700. [6] Meaudre E, Boret H, Suppini A, et al. Sufentanil supplementation of sevoflurane during induction of anaesthesia: a randomized study[J]. Eur J Anaesthesiol, 2004, 21 (10): 793-796. [7] Bailey PL, Streisand JB, East KA, et al. Differences in magnitude and duration of opiod-induced respiratory depression and analgesia with fentanyl and sufentanil[J]. Anesth Analg, 1990, 70(1): 8-15. [8] Recart A, Gasanova I, White PF, et al. The effect of cerebral monitoring on recovery after general anesthesia: a comparison of the auditory evoked potential and bispectral index devices with standard clinical practice[J]. Anesth Analg, 2003, 97(6): 1667-1674. [9] Hughes MA, Glass PSA, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs[J]. Anesthesiology, 1992, 76 (3): 334-341. [10] Wong CA, Fragen RJ, Fitzgerald P, et al. A comparison of the SNAP II and BIS XP indices during sevoflurane and nitrous oxide anaesthesia at 1 and 1.5 MAC and at awakening[J]. Br J Anaesth, 2006, 97(2): 181-186. |